Classifications and Treatment Responses in Chronic Immune-Mediated Demyelinating Polyneuropathy
Neurol 68:1622-1629, Tackenberg,B.,et al, 2007
Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007
Intermittent Cyclophosphamide With Prednisone Versus Placebo for Polyneuropathy With IgM Monoclonal Gammopathy
Neurol 69:50-59, Niermeijer,J.M.F.,et al, 2007
Neuroimaging Findings in Human Prion Disease
JNNP 78:664-670, Macfarlane,R.G.,et al, 2007
Small Vessels, Big Problems
NEJM 354:1451-1453, Greenberg,S.M., 2006
A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006
Clinicopath Conf, Charcot-Marie-Tooth Disease Type 2, with Aides Pupil and a Mutation in MPZ Gene
NEJM 354:2584-2592, Case 18-2006, 2006
Early Clinical Signs and Imaging Findings in Gerstmann-Straussler-Scheinker Syndrome (Pro102Leu)
Neurol 66:1672-1678, Arata,H.,et al, 2006
Frontotemporal Dementia: Clinicopathological Correlations
Ann Neurol 59:952-962, Forman,M.S.,et al, 2006
White Matter Alterations in Cerebral Amyloid Angiopathy Measured by Diffusion Tensor Imaging
Stroke 37:1759-1764, Salat,D.H., 2006
Kuru in the 21st Century--An Acquired Human Prion Disease With Very Long Incubation Periods
Lancet 367:2068-2074, Collinge,J.,et al, 2006
Progression of White Matter Lesions and Hemorrhages in Cerebral Amyloid Angiopathy
Neurol 67:83-87, Chen,Y.W.,et al, 2006
Onset of Creutzfeldt-Jakob Disease Mimicking an Acute Cerebrovascular Event
Neurol 67:538-539, Hohler,A.D. &Flynn,F.G., 2006
Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006
Episodic Neurologic Dysfunction with Migraine and Reversible Imaging Findings After RadiationRRH
Neurol 67:676-678, Pruitt,A.,et al, 2006
CSF Tests in the Differential Diagnosis of Cretuzfeldt-Jakob Disease
Neurol 67:637-643, Sanchez-Juan,P.,et al, 2006
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Dementia and White-Matter Demyelination in Young Patient With Neurosyphilis
Lancet:368:2258, Brinar,V.V. &Habek,M., 2006
Detection of CSF 14-3-3 Protein in Guillain-Barr Syndrome
Neurol 67:2211-2216, Bersano,A.,et al, 2006
Pupil Findings in a Consecutive Series of 150 Patients with Generalised Autonomic Neuropathy
JNNP 77:1163-1168, Bremner,F. &Smith,S., 2006
Multiple Sclerosis with and without CSF Bands:Clinically Indistinguishable but Immunogenetically Distinct
Neurol 67:1062-1064, Imrell,K.,et al, 2006
Treatment With Interferon beta-1b Delays Conversion to Clinically Definite and McDonald MS in Patients With Clinically Isolated Syndromes
Neurol 67:1242-1249, Kappos,L.,et al, 2006
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Clinicopath Conf., Degoss Disease
NEJM 355:2575-2584, Case 38-2006, 2006
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension
JAMA 295:2286-2296, Schievink,W.I., 2006
Cerebral Microhemorrhage
Stroke 37:550-555, Viswanathan,A. &Chabriat,H., 2006
Cerebral Microbleeds on MRI
Neurol 66:165-171, Koennecke,H.-C., 2006
Cerebral Amyloid Angiopathy and Lobar Intracerebral Hemorrhage
Arch Neurol 63:148-151, Smith,E.E. &Eichler,F., 2006
CSF Findings in 250 Patients with Serologically Confirmed West Nile Virus Meningitis and Encephalitis
Neurol 66:361-365, Tyler,K.L.,et al, 2006
Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006
Alexander Disease, Ventricular Garlands and Abnormalities of the Medulla and Spinal Cord
Neurol 66:494-498,468, van der Knaap,M.S.,et al, 2006
Left Insular Stroke is Associated with Adverse Cardiac Outcome
Neurol 66:477-483, Laowattana,S.,et al, 2006
Clinically Isolated Syndromes, A New Oligoclonal Band Test Accurately Predicts Conversion to MS
Neurol 66:576-578, Masjuan,J.,et al, 2006
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
IM Interferon B-1a Delays Definite Multiple Sclerosis 5 Years After a First Demyelinating Event
Neurol 66:678-684, CHAMPIONS Study Group, 2006
Frontotemporal Lobar Degeneration with Motor Neuron Disease
Arch Neurol 63:489-490, Clark,C.M. &Forman,M.S., 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Arch Neurol 63:665-672,645, Petersen,R.C.,et al, 2006
Neuropathology of the Neuroradiologist: Rosenthal Fibers
AJNR 27:958-961, Wippold,F., II,et al, 2006
Syncope and Falls Due to Timolol Eye Drops
BMJ 332:960-961, Mller,M.E.,et al, 2006
Concomitant Chronic Inflammatory Demyelinating Polyneuropathy and Myasthenia Gravis Following Cytomegalovirus Infection
J Neurol Sci 240:103-106, Mori, M.,et al, 2006
Treatment and Prevention of Primary Intracerebral Hemorrhage
Semin Neurol 25:445-452, Towfighi,A.,et al, 2005
Verapamil Induced Gingival Enlargement in Cluster Headache
JNNP 76:124-127, Matharu,M.S.,et al, 2005
Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by Coma
NEJM 352:686-691, de Jong,M.D., et al, 2005
Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005
Neurocardiogenic Syncope
NEJM 352:1004-1010, Grubb, B.P., 2005
Role of Cerebral Amyloid Angiopathy in Intracerebral Hemorrhage in Hypertensive Patients
Neurol 64:1233-1237, Ritter,M.A.,et al, 2005
Autonomic Peripheral Neuropathy
Lancet 365:1259-1270, Freeman,R., 2005
FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005
Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis
Arch Neurol 62:785-792, Schwid,S.R.,et al, 2005